Continuous phenobarbital treatment and palmoplantar fibromatosis
Orthopedic surgery department B, University Hospital Center Mohammed-VI, University Mohammed-I Oujda Morocco.
Research Article
World Journal of Advanced Research and Reviews, 2020, 05(02), 060-066
Article DOI: 10.30574/wjarr.2020.5.2.0029
Publication history:
Received on 29 January 2020; revised on 10 February 2020; accepted on 12 February 2020
Abstract:
Palmoplantar disease is a hyperproliferative disorder with dystrophic nodules in the superficial plantar and palmar fascia. It can be associated with other pathologies such as Lapeyronie’s desease, diabetes, alcohol dependence or continuous phenobarbital treatment. We report the rare case of a pathological association made of Ledderhose's disease, Dupuytren's disease and barbiturates in an epileptic patient. Conservative treatment well conducted for more than 6 months is not satisfactory. A complete fasciectomy is performed with good functional results without recurrence. The association between epilepsy and palmoplantar fibromatosis is extremely rare. The role of barbiturates in mediating tissue growth factors would in theory explain this hyperproliferative disorder of the plantar fascia. The association between fibromatosis and cell growth mediators evokes new approaches aimed at modulating these cells for better therapeutic control.
Keywords:
Ledderhose disease; Palmoplantar fibrosis; Epilepsy
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0